Please use this identifier to cite or link to this item: http://dx.doi.org/10.25673/37433
Full metadata record
DC FieldValueLanguage
dc.contributor.authorZlomke, Christin-
dc.contributor.authorAlbrecht, Johannes-
dc.contributor.authorMäder, Karsten-
dc.date.accessioned2021-07-26T08:22:31Z-
dc.date.available2021-07-26T08:22:31Z-
dc.date.issued2020-
dc.identifier.urihttps://opendata.uni-halle.de//handle/1981185920/37676-
dc.identifier.urihttp://dx.doi.org/10.25673/37433-
dc.description.abstractThe aim of the study was to develop nicardipine loaded phospholipid extrudates as an alternative for PLA/PLGA-based implants for the prevention of cerebral vasospasms. Extrudates of different mixtures of saturated and unsaturated phosphatidylcholine (PC) were produced and characterized by DSC, microscopy and texture analysis. Single phospholipid components were identified by ELSD-HPLC. Extrudates of 2 mm diameter were obtained by twin screw extrusion temperatures below 50 °C. The ratio of unsaturated and saturated phosphatidylcholine components determines the physicochemical properties of the extrudates as well as the rate of erosion. Nicardipine loaded phospholipids extrudates released the drug over several weeks in vitro. The phospholipid composition of the remaining extrudate changed during the release, the content of unsaturated phospholipids decreased faster compared to the saturated ones. In conclusion, solid phospholipid extrudates are promising materials for the development of new parenteral controlled release systems.eng
dc.description.sponsorshipPublikationsfond MLU-
dc.language.isoeng-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subject.ddc615-
dc.titleNicardipine loaded solid phospholipid extrudates for the prevention of cerebral vasospasms : in vitro characterizationeng
dc.typeArticle-
local.versionTypepublishedVersion-
local.bibliographicCitation.journaltitlePharmaceutics-
local.bibliographicCitation.volume12-
local.bibliographicCitation.issue9-
local.bibliographicCitation.publishernameMDPI-
local.bibliographicCitation.publisherplaceBasel-
local.bibliographicCitation.doi10.3390/pharmaceutics12090817-
local.subject.keywordsphospholipid; phosphatidylcholine; lecithin; controlled release; implant; extrusion; parenteral; biodegradable; nicardipine; dihydropyridine-
local.openaccesstrue-
dc.identifier.ppn1728493560-
local.bibliographicCitation.year2020-
cbs.sru.importDate2021-07-26T08:21:24Z-
local.bibliographicCitationEnthalten in Pharmaceutics - Basel : MDPI, 2009-
local.accessrights.dnbfree-
Appears in Collections:Open Access Publikationen der MLU

Files in This Item:
File Description SizeFormat 
pharmaceutics-12-00817.pdf6.67 MBAdobe PDFThumbnail
View/Open